Home  »  Hot Stocks   »  Wall Street Pummels Kezar Life Sciences Inc. (KZR)...

Wall Street Pummels Kezar Life Sciences Inc. (KZR) After Recent Earnings Report

Kezar Life Sciences Inc. (NASDAQ:KZR) went down by -5.66% from its latest closing price compared to the recent 1-year high of $18.55. The company’s stock price has collected -11.45% of loss in the last five trading sessions.

Is It Worth Investing in Kezar Life Sciences Inc. (NASDAQ :KZR) Right Now?

Plus, the 36-month beta value for KZR is at 0.16. Opinions of the stock are interesting as 6 analysts out of 6 who provided ratings for Kezar Life Sciences Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


The average price from analysts is $18.75, which is $10.09 above the current price. KZR currently public float of 54.07M and currently shorts hold a 12.91% ratio of that float. Today, the average trading volume of KZR was 2.22M shares.

KZR’s Market Performance

KZR stocks went down by -11.45% for the week, with a monthly drop of -12.96% and a quarterly performance of 63.71%, while its annual performance rate touched -11.00%. The volatility ratio for the week stands at 8.93% while the volatility levels for the past 30 days are set at 5.84% for Kezar Life Sciences Inc. The simple moving average for the period of the last 20 days is -12.25% for KZR stocks with a simple moving average of -24.58% for the last 200 days.

Analysts’ Opinion of KZR

Many brokerage firms have already submitted their reports for KZR stocks, with Wells Fargo repeating the rating for KZR by listing it as a “Overweight.” The predicted price for KZR in the upcoming period, according to Wells Fargo is $19 based on the research report published on December 08th of the previous year 2021.

Wells Fargo gave a rating of “Outperform” to KZR, setting the target price at $30 in the report published on July 16th of the previous year.

KZR Trading at -13.28% from the 50-Day Moving Average

After a stumble in the market that brought KZR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.32% of loss for the given period.

Volatility was left at 5.84%, however, over the last 30 days, the volatility rate increased by 8.93%, as shares sank -14.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.33% lower at present.

During the last 5 trading sessions, KZR fell by -11.45%, which changed the moving average for the period of 200-days by -38.63% in comparison to the 20-day moving average, which settled at $9.80. In addition, Kezar Life Sciences Inc. saw -48.21% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at KZR starting from BERGER FRANKLIN M, who purchase 20,000 shares at the price of $14.77 back on Mar 21. After this action, BERGER FRANKLIN M now owns 890,691 shares of Kezar Life Sciences Inc., valued at $295,400 using the latest closing price.

BERGER FRANKLIN M, the Director of Kezar Life Sciences Inc., purchase 60,000 shares at $16.74 during a trade that took place back on Mar 18, which means that BERGER FRANKLIN M is holding 870,691 shares at $1,004,400 based on the most recent closing price.

Stock Fundamentals for KZR

Equity return is now at value -28.80, with -26.50 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 25.77.

Is FedEx Corporation (FDX) a Keeper?

FedEx Corporation (NYSE:FDX) went up by 1.55% from its latest closing price compared to the recent 1-year high of $266.79. The company’s stock price has